Vastra Frolunda, Sweden

Nils P Stjernlof


Average Co-Inventor Count = 9.0

ph-index = 4

Forward Citations = 71(Granted Patents)


Location History:

  • Angered, SE (1993)
  • 421 69 Vastra Frolunda, SE (1995)
  • Vastra Frolunda, SE (1994 - 1997)

Company Filing History:


Years Active: 1993-1997

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Nils P. Stjernlof: Innovator in Central Nervous System Treatments

Introduction

Nils P. Stjernlof is a notable inventor based in Vastra Frolunda, Sweden. He has made significant contributions to the field of pharmacology, particularly in developing compounds for treating central nervous system disorders. With a total of six patents to his name, Stjernlof's work has had a profound impact on medical science.

Latest Patents

Stjernlof's latest patents include innovative compounds such as "Centrally acting 6,7,8,9-tetrahydro-3H-benz(e) indole heterocyclics." This compound is designed to treat disorders of the central nervous system, particularly as 5-HT1A receptor agonists. Another significant patent is for "Centrally acting substituted phenylazacycloalkanes," which possesses selective pharmacological properties useful in treating various conditions related to dopamine receptor activity, including depression and schizophrenia.

Career Highlights

Throughout his career, Stjernlof has worked with prominent companies, including The Upjohn Company. His innovative research has led to the development of compounds that address critical health issues, showcasing his dedication to improving mental health and motor functions.

Collaborations

Stjernlof has collaborated with notable colleagues such as Hakan V. Wikstrom and Per A. Carlsson. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Nils P. Stjernlof is a distinguished inventor whose work in pharmacology has led to significant advancements in treating central nervous system disorders. His innovative patents and collaborations highlight his commitment to improving health outcomes through scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…